Form 8-K PUMA BIOTECHNOLOGY, INC. For: Aug 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Puma Biotechnology, Inc. (PBYI) Posts Q2 Loss of $1.05/Share
August 11, 2014 4:51 PM EDTPuma Biotechnology, Inc. (NYSE: PBYI) reported Q2 EPS of ($1.05), $0.39 worse than the analyst estimate of ($0.66).
For earnings history and earnings-related data on Puma Biotechnology, Inc. (PBYI) click here.
... More